These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

902 related items for PubMed ID: 11981591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
    Deshpande LS, Khisti RT, Chopde CT.
    Brain Res; 2001 Apr 13; 898(1):13-26. PubMed ID: 11292445
    [Abstract] [Full Text] [Related]

  • 3. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD.
    J Pharmacol Exp Ther; 1997 Dec 13; 283(3):1256-63. PubMed ID: 9400001
    [Abstract] [Full Text] [Related]

  • 4. Adenosinergic modulation of 3alpha-hydroxy-5alpha-pregnan-20-one induced catalepsy in mice.
    Mandhane SN, Khisti RT, Chopde CT.
    Psychopharmacology (Berl); 1999 Jun 13; 144(4):398-404. PubMed ID: 10435413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 13; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D, Priebe K, Johnstone-Miller E, Morgan CJ.
    Psychopharmacology (Berl); 2002 Jul 13; 162(2):138-46. PubMed ID: 12110991
    [Abstract] [Full Text] [Related]

  • 11. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
    Xue BG, Whittemore ER, Park CH, Woodward RM, Lan NC, Gee KW.
    J Pharmacol Exp Ther; 1997 Jun 13; 281(3):1095-101. PubMed ID: 9190841
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one.
    Hirani K, Khisti RT, Chopde CT.
    Neuropharmacology; 2002 Dec 13; 43(8):1339-50. PubMed ID: 12527484
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF, Seymour PA, Schmidt AW, Zorn SH, Schulz DW, Lebel LA, McLean S, Guanowsky V, Howard HR, Lowe JA.
    J Pharmacol Exp Ther; 1995 Oct 13; 275(1):101-13. PubMed ID: 7562537
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG, Downs DA, Meltzer LT, Wiley JN, Williams AE.
    J Pharmacol Exp Ther; 1989 Oct 13; 251(1):105-12. PubMed ID: 2571712
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one in male and female rats.
    Janis GC, Devaud LL, Mitsuyama H, Morrow AL.
    Alcohol Clin Exp Res; 1998 Dec 13; 22(9):2055-61. PubMed ID: 9884151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.